Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFD-03 Lotion in Acne Vulgaris
NCT03292640Phase 3Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Jul 2017
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tazarotene in acne vulgaris, sponsored by Dr. Reddy's Laboratories. Started Jul 2017; status: completed.
02
Drugs
tazarotene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03292640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03292640.